Personal information

No personal information available

Activities

Works (16)

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Journal for ImmunoTherapy of Cancer
2022-11 | Journal article
Part of ISSN: 2051-1426
Contributors: Matthew G. Cyr; MAISSA MHIBIK; Junpeng Qi; haiyong peng; Jing Chang; Erika M Gaglione; David Eik; John Herrick; Thomas Venables; Scott J Novick et al.
Source: Self-asserted source
Junpeng Qi

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Blood
2021-11-11 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Contributors: MAISSA MHIBIK; Erika M. Gaglione; David Eik; Ellen K. Kendall; Amy Blackburn; Keyvan Keyvanfar; Maria Joao Baptista; Inhye E. Ahn; Clare Sun; Junpeng Qi et al.
Source: Self-asserted source
Junpeng Qi

Redirecting cytotoxic T cells with chemically programmed antibodies

Bioorganic & Medicinal Chemistry
2020-12 | Journal article
Part of ISSN: 0968-0896
Contributors: Junpeng Qi; Christoph Rader
Source: Self-asserted source
Junpeng Qi

Expert’s views and perspectives: an interview with distinguished investigator Dr. Ira Pastan at the National Cancer Institute at NIH

Antibody Therapeutics
2020-07-25 | Journal article
Part of ISSN: 2516-4236
Contributors: Peng Lin; Junpeng Qi; Weijing Liu
Source: Self-asserted source
Junpeng Qi

Chemically Programmable and Switchable CAR‐T Therapy

Angewandte Chemie International Edition
2020-07-13 | Journal article
Part of ISSN: 1433-7851
Part of ISSN: 1521-3773
Contributors: Junpeng Qi; Kohei Tsuji; David Hymel; Terrence R. Burke; Michael Hudecek; Christoph Rader; Haiyong Peng
Source: Self-asserted source
Junpeng Qi

Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications

Journal of Biological Chemistry
2020-05 | Journal article
Part of ISSN: 0021-9258
Contributors: Rebecca S. Goydel; Justus Weber; Haiyong Peng; Junpeng Qi; Jo Soden; Jim Freeth; HaJeung Park; Christoph Rader
Source: Self-asserted source
Junpeng Qi

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Blood
2019-11-13 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Contributors: Maissa Mhibik; Erika M Gaglione; Amy Blackburn; Keyvan Keyvanfar; Clare Sun; Inhye E Ahn; Maria Joao Baptista; Junpeng Qi; Christoph Rader; Adrian Wiestner
Source: Self-asserted source
Junpeng Qi

Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1

Frontiers in Immunology
2019-08-21 | Journal article
Part of ISSN: 1664-3224
Contributors: Junpeng Qi; David Hymel; Christopher G. Nelson; Terrence R. Burke; Christoph Rader
Source: Self-asserted source
Junpeng Qi

An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies

Methods
2019-02 | Journal article
Part of ISSN: 1046-2023
Contributors: Junpeng Qi; Shih-Shih Chen; Nicholas Chiorazzi; Christoph Rader
Source: Self-asserted source
Junpeng Qi

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

Blood
2018-08-02 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Contributors: Hannah R. Robinson; Junpeng Qi; Erika M. Cook; Cydney Nichols; Eman L. Dadashian; Chingiz Underbayev; Sarah E. M. Herman; Nakhle S. Saba; Keyvan Keyvanfar; Clare Sun et al.
Source: Self-asserted source
Junpeng Qi

Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1

Proceedings of the National Academy of Sciences
2018-06-12 | Journal article
Part of ISSN: 0027-8424
Part of ISSN: 1091-6490
Contributors: Junpeng Qi; Xiuling Li; Haiyong Peng; Erika M. Cook; Eman L. Dadashian; Adrian Wiestner; HaJeung Park; Christoph Rader
Source: Self-asserted source
Junpeng Qi

Activity of CD19/CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia

Blood
2017-12-07 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Contributors: Hannah R. Robinson; Junpeng Qi; Sivasubramanian Baskar; Erika Cook; Inhye E. Ahn; Sarah E. M. Herman; Christoph Rader; Adrian Wiestner
Source: Self-asserted source
Junpeng Qi

Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility

Journal of Molecular Biology
2017-09 | Journal article
Part of ISSN: 0022-2836
Contributors: Haiyong Peng; Thomas Nerreter; Jing Chang; Junpeng Qi; Xiuling Li; Pabalu Karunadharma; Gustavo J. Martinez; Mohammad Fallahi; Jo Soden; Jim Freeth et al.
Source: Self-asserted source
Junpeng Qi

CD19/CD3 bispecific antibodies induce potent response against chronic lymphocytic leukemia cells <i>ex vivo</i>

The Journal of Immunology
2017-05-01 | Journal article
Part of ISSN: 0022-1767
Part of ISSN: 1550-6606
Contributors: Hannah Ruth Robinson; Junpeng Qi; Sivasubramanian Baskar; Christoph Rader; Adrian Wiestner
Source: Self-asserted source
Junpeng Qi

Chemically Programmed Bispecific Antibodies in Diabody Format

Journal of Biological Chemistry
2016-09 | Journal article
Part of ISSN: 0021-9258
Contributors: Even Walseng; Christopher G. Nelson; Junpeng Qi; Alex R. Nanna; William R. Roush; Rajib K. Goswami; Subhash.C. Sinha; Terrence R. Burke; Christoph Rader
Source: Self-asserted source
Junpeng Qi

Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates

Journal of Biological Chemistry
2016-04 | Journal article
Part of ISSN: 0021-9258
Contributors: Mohosin Sarkar; Yun Liu; Junpeng Qi; Haiyong Peng; Jumpei Morimoto; Christoph Rader; Nicholas Chiorazzi; Thomas Kodadek
Source: Self-asserted source
Junpeng Qi